LINC-PINT and cholangiocarcinoma: Remarkably, in stark contrast, we observed a notable upregulation of LINC-PINT in Cholangiocarcinoma (CHOL), Colon Adenocarcinoma (COAD), Liver Hepatocellular Carcinoma (LIHC), Rectum Adenocarcinoma (READ), and Stomach Adenocarcinoma (STAD).